MCRB - Seres Therapeutics GAAP EPS of $0.36 misses by $0.17 revenue of $126.47M beats by $0.8M
2023-08-08 07:11:21 ET
- Seres Therapeutics press release ( NASDAQ: MCRB ): Q2 GAAP EPS of $0.36 misses by $0.17 .
- Revenue of $126.47M (+10266.4% Y/Y) beats by $0.8M .
For further details see:
Seres Therapeutics GAAP EPS of $0.36 misses by $0.17, revenue of $126.47M beats by $0.8M